Source: Medical devices and technologies
Archeus Technologies Inc. has obtained IND clearance from the FDA for ART-101, a novel receptor-based targeting small molecule for the imaging and treatment of prostate cancer.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
